KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Gross Margin (2016 - 2025)

Historic Gross Margin for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to 28.98%.

  • Medpace Holdings' Gross Margin fell 42500.0% to 28.98% in Q4 2025 from the same period last year, while for Dec 2025 it was 30.06%, marking a year-over-year decrease of 10600.0%. This contributed to the annual value of 30.06% for FY2025, which is 10600.0% down from last year.
  • Latest data reveals that Medpace Holdings reported Gross Margin of 28.98% as of Q4 2025, which was down 42500.0% from 29.84% recorded in Q3 2025.
  • Over the past 5 years, Medpace Holdings' Gross Margin peaked at 33.23% during Q4 2024, and registered a low of 26.82% during Q2 2021.
  • Its 5-year average for Gross Margin is 29.49%, with a median of 29.64% in 2021.
  • Its Gross Margin has fluctuated over the past 5 years, first skyrocketed by 57800bps in 2024, then crashed by -42500bps in 2025.
  • Medpace Holdings' Gross Margin (Quarter) stood at 28.52% in 2021, then increased by 3bps to 29.37% in 2022, then dropped by -7bps to 27.45% in 2023, then rose by 21bps to 33.23% in 2024, then fell by -13bps to 28.98% in 2025.
  • Its Gross Margin stands at 28.98% for Q4 2025, versus 29.84% for Q3 2025 and 29.84% for Q2 2025.